Drug profile · INN
enasidenib mesylate
IDHIFA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
enasidenib mesylate (IDHIFA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN enasidenib mesylate
Brand IDHIFA
Route ORAL
Formulation TABLET
Frequently asked questions
What is enasidenib mesylate?
enasidenib mesylate (IDHIFA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for enasidenib mesylate?
IDHIFA is a marketed brand name for enasidenib mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enasidenib mesylate?
enasidenib mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.